Inactive Instrument
Abliva AB Share Price
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 10/01/2014 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/2023 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 06/11/2017 | |
| Director/Board Member | 66 | 27/04/2017 | |
David Bejker
BRD | Director/Board Member | 51 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/03/25 | Sell | Founder | 5,74,978 | 0.0357% | ||
| 07/03/25 | Sell | Founder | 5,74,978 | 0.0357% | ||
| 12/02/25 | Sell | Chief Technology Officer | 31,04,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 7.6Cr | |
| +0.79% | -6.16% | +49.32% | +74.50% | 6.63TCr | |
| -0.54% | +5.71% | +10.82% | +88.89% | 5.29TCr | |
| +0.51% | +4.99% | +7.61% | +73.74% | 5.48TCr | |
| +1.84% | +2.75% | +26.31% | +45.29% | 4.41TCr | |
| +0.49% | +10.15% | +20.69% | +132.73% | 4.37TCr | |
| +0.63% | +4.30% | +263.91% | +602.72% | 4.21TCr | |
| -0.40% | +9.85% | +17.04% | +59.17% | 3.4TCr | |
| -1.30% | -0.68% | +37.15% | +7.04% | 2.62TCr | |
| +0.54% | +4.47% | +35.14% | +25.04% | 2.34TCr | |
| Average | -0.07% | +4.96% | +52.00% | +123.23% | 4.31TCr | |
| Weighted average by Cap. | -0.02% | +4.85% | +51.14% | +128.15% |
Employees
6
